• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-08-30

  Saito and colleagues developed an accessible direct 3D culture strategy for generating intestinal organoids from human induced pluripotent stem cells. The resulting organoids could be expanded, cryopreserved, and differentiated into epithelial cells with enterocyte CYP and transporter activities, supporting more human-relevant in vitro pharmacokinetic studies.

• Central Control of Opioid Mechanical Hypersensitivity

  2026-08-29

  Yin et al. identify a brain-to-spinal µ-opioid receptor circuit linking the lateral parabrachial nucleus, paraventricular hypothalamus, and spinal dorsal horn to morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The study shows that local MOR activation can paradoxically promote mechanical pain hypersensitivity and that pathway-specific intervention can restore morphine responsiveness.

• Dimetridazole: Mechanism to Translational Strategy

  2026-08-28

  A mechanistic and strategic guide to using Dimetridazole in antimicrobial, quorum-sensing, combination, infection-model, sensing, and environmental-fate research—without confusing laboratory utility with clinical readiness.

• Tranexamic Acid Workflows for Fibrinolysis Research

  2026-08-28

  Build cleaner clot-stability and cell-adherence experiments with a water-compatible antifibrinolytic agent. This guide translates Tranexamic Acid from concentration-response assays into composite wound-dressing research while separating direct TXA effects from contributions by nitric oxide and propolis.

• CAY10499 for Lipid–Immune Metabolism Assays

  2026-08-27

  CAY10499 is an inhibitor of human hormone sensitive lipase and monoglyceride lipase that enables mechanistic lipid metabolism assays. This article explains how to use its enzyme profile to dissect fatty-acid mobilization and endocannabinoid regulation alongside EV-driven macrophage biology in hepatocellular carcinoma.

• ER Stress and Intestinal Stem Cell Injury

  2026-08-27

  The reference study shows that tunicamycin-induced endoplasmic reticulum stress damages the mouse small-intestinal mucosa by reducing intestinal stem-cell abundance and differentiation while increasing crypt apoptosis. Its main mechanistic contribution is the association of this phenotype with GRP78/ATF6/CHOP activation and suppression of p44/42 MAPK signaling, providing a framework for studying stress-driven epithelial failure.

• 4μ8C: A Translational Lens on IRE1α Biology

  2026-08-26

  4μ8C is more than a selective IRE1α RNase inhibitor: it is a precision tool for separating ER stress signaling from cell-fate outcomes. This thought-leadership analysis connects its use in hypoxic cancer models with new evidence that mono-ADP-ribosylation and ubiquitin-dependent degradation can rapidly reshape stress-responsive transcriptional programs.

• HA-LNP PTEN mRNA for Transdermal Melanoma Immunotherapy

  2026-08-26

  A 2026 Journal of Controlled Release study developed hyaluronate-conjugated lipid nanoparticles containing PTEN mRNA for non-invasive delivery through melanoma-bearing skin. By integrating HA-DMG into the lipid nanoparticle during self-assembly, the platform combined CD44-directed targeting with topical administration, restored PTEN expression, reduced melanoma viability, and enhanced antitumor immune activity in preclinical models.

• Protease Inhibitor Cocktail: MS-Compatible Use

  2026-08-25

  Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) helps limit endogenous proteolysis during cell and tissue protein extraction while avoiding AEBSF in mass spectrometry workflows. It is not a complete metalloproteinase or phosphatase inhibitor system; EDTA must be evaluated and added separately when metalloproteinase inhibition is required.

• Atorvastatin Workflows for Ferroptosis Research

  2026-08-25

  Atorvastatin is a practical HMG-CoA reductase inhibitor for connecting mevalonate-pathway biology with ferroptosis, vascular signaling, and liver cancer models. This workflow-focused guide covers dosing design, orthogonal validation, solubility control, and interpretation of preclinical findings.

• HA-LNP PTEN mRNA for Transdermal Melanoma Therapy

  2026-08-24

  A 2026 Journal of Controlled Release study developed hyaluronate-conjugated lipid nanoparticles for topical delivery of PTEN mRNA through skin and into melanoma tissue. The platform combined HA-mediated CD44 targeting with localized tumor-suppressor restoration, producing antitumor and immune-activating effects in cellular and mouse models while avoiding an invasive administration route.

• Hoechst 33342: Reliable Nuclear Staining

  2026-08-24

  Learn how Hoechst 33342 (SKU A3472) supports standardized nuclear visualization in live-cell, proliferation, apoptosis, and cytotoxicity workflows. This scenario-based guide covers dye principles, protocol parameters, interpretation limits, and practical vendor-selection criteria.

• Scutellarin, Cathepsin D, and Cardiac I/R Injury

  2026-08-23

  A 2025 Frontiers in Pharmacology study identifies cathepsin D as a mechanistic link between scutellarin treatment and recovery of autophagy-lysosomal function during ischemia/reperfusion injury. Using rat coronary ligation/release and endothelial oxygen-glucose deprivation/reoxygenation models, the researchers show that pharmacological or genetic disruption of cathepsin D eliminates scutellarin-associated vascular and cellular protection.

• Ceruletide as a Mechanistic Probe in Pancreatic Fibrosis

  2026-08-22

  Ceruletide, also known as Caerulein, can do more than induce pancreatic injury: it can help researchers distinguish secretagogue-driven damage from downstream antifibrotic signaling. This article presents a mechanism-oriented framework connecting Ceruletide models with MFGE8-dependent ANXA1-SMAD2/3 biology and regenerative nanomedicine.

• Glucose Uptake Assays in Delivery-Aware Metabolism

  2026-08-22

  Translational glucose biology increasingly depends on connecting metabolic phenotypes with delivery conditions. This thought-leadership guide explains the WST-8 assay mechanism, shows how ion-modulated nucleic acid delivery can shape experimental context, and outlines a rigorous strategy for interpreting cellular glucose uptake data.

7896 records 1/527 page Next 12345 下5页 Last page